© 2017 by the Society of Nuclear Medicine and Molecular Imaging. Intermodality changes were 3 times more likely than intramodality changes, underlining the clinical impact of SSTR PET/CT.ĭOTATATE DOTATOC GI PET/CT SSTR management neuroendocrine oncology peptides. An ArangoDB server contains a list of users. ArangoDB user accounts are valid throughout a server instance (across databases). Additional users can be created and granted different actions and access levels.
#Uid key in arangodb password
Conclusion: The management was changed in more than one third of patients undergoing SSTR PET/CT even when performed after an 111In-Octreotide scan. Note that it has an empty password by default, so make sure to set a strong password immediately. Seven of 14 studies differentiated between inter- and intramodality changes, with most changes being intermodality (77% intramodality, 23%). In this subgroup, additional information by SSTR PET/CT led to a change in management in 39% (range, 16%-71%) of patients. In 4 of 14 studies, SSTR PET/CT was performed after an 111In-Octreotide scan. Overall, change in management occurred in 44% (range, 16%-71%) of NET patients after SSTR PET/CT. Results: A total of 1,561 patients were included. Change in management across studies was determined by a random-effects model.
![uid key in arangodb uid key in arangodb](https://www.idplate.com/sites/default/files/2019-11/UID.jpg)
![uid key in arangodb uid key in arangodb](https://cdn.linuxid.net/assets/media/ubuntu/33477/page-4-Select-storage-engine.png)
Fourteen of 190 studies were deemed suitable based on the following inclusion criteria: original research, cohort study, number of patients 10 or more, and reported change in management after SSTR PET/CT. Methods: A comprehensive literature search was performed using The National Center for Biotechnology Information PubMed online database, applying the following key words: "management" AND "PET" AND "neuroendocrine". Here, we performed a systematic review and meta-analysis to evaluate the impact of SSTR PET/CT on the management of patients with NETs. I however believe it is best to maintain separate documents and rather use joins when retrieving. Food and Drug Administration has triggered widespread clinical interest in SSTR PET/CT throughout the United States. here arangodb-aql-update-single-object-in-embedded-array and there arangodb-aql-update-for-internal-field-of-object. web interface aql query returns more than 1000 items, arangod gets segment fault (core dump) 6174. These are the top rated real world JavaScript examples of org/arangodb/foxx.Model extracted from open source projects.
![uid key in arangodb uid key in arangodb](https://framalibre.org/sites/default/files/styles/screenshot/public/screenshot3_2.png)
jsteemann mentioned this issue on Aug 16, 2018. my environment running ArangoDB I'm using the latest ArangoDB of the respective release series: 2.8 3.0 3.1 3.2 self-compiled devel branch Mode: Cluster Single-Server Storage-Engine: mmfiles ro. Service stops right after running a query 6131. jsteemann mentioned this issue on Aug 9, 2018. Somatostatin receptor (SSTR) imaging is widely used for guiding the management of neuroendocrine tumor (NET) patients. fixed issue 6076: Segmentation fault after AQL query ( 6081) Verified.